CD44 and hepatocellular carcinoma: In the present study, we evaluated the effect of up-regulated FAM83D on HCC initiation, progression and recurrence and verified that FAM83D promotes CD44 overexpression via activating MAPK, TGF-β and Hippo signaling pathways.